Evidence map›Paper›PMID 41672888›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Nanozyme Aptasensor Array for Predictive Sensing of Virulent and Antibiotic-Resistant Staphylococcus Aureus strains.

Pabudi Weerathunge, Mahdieh Yazdani, Tarun K Sharma, Wilson K M Wong, Mugdha V Joglekar, Anandwardhan A Hardikar, Vincent M Rotello, Rajesh Ramanathan, Vipul Bansal

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pabudi WeerathungeSir Ian Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria, Australia.
Mahdieh YazdaniDepartment of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
Tarun K SharmaDepartment of Medical Devices, National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India.
Wilson K M WongSchool of Medicine, Diabetes & Islet Biology Group, Faculty of Health, Western Sydney University, Campbelltown, New South Wales, Australia.
Mugdha V JoglekarSchool of Medicine, Diabetes & Islet Biology Group, Faculty of Health, Western Sydney University, Campbelltown, New South Wales, Australia.
Anandwardhan A HardikarSchool of Medicine, Diabetes & Islet Biology Group, Faculty of Health, Western Sydney University, Campbelltown, New South Wales, Australia.
Vincent M RotelloDepartment of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
Rajesh RamanathanSir Ian Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria, Australia.
Vipul BansalSir Ian Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-3354-4317

Funding

Ainsworth Medical Research Fund through Western Sydney UniversityARC Industry Transformation Hub IH240100013Australian Research Council (ARC) Discovery scheme DP230101650RMIT Microscopy and Microanalysis FacilityRMIT University Career Reignite Funding
6 · The paper itself

Abstract

Staphylococcus aureus, an important human pathogen, is the leading cause of infection-related death globally. It stands out as the only bacterial pathogen, apart from Mycobacterium tuberculosis, responsible for over a million fatalities each year. The emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), has created challenges in detecting S. aureus infections, as treatment depends on identifying the specific strain causing the infection. This study highlights the use of an array-based colorimetric aptasensor platform using aptamers, which exhibit specific binding across different S. aureus strains. This platform generates unique colorimetric fingerprints for different S. aureus strains, thus enabling an unbiased and strain-specific detection system. The unique signatures arise from differences in the dissociation dynamics of aptamers on the surface of nanozymes. The sensor response was analysed using pattern recognition tools trained on responses from the aptasensor array to identify individual S. aureus strains. Furthermore, the sensing platform offers additional functionality by providing information about the virulence factors associated with pathogenicity, such as the presence of markers like Panton-Valentine leukocidin (pvl), which is a marker of increased virulence and sensitivity/resistance to antibiotics. The platform would be capable of recognising previously unencountered S. aureus strains, enabling predictive capabilities and utility in clinical diagnostics.

Indexed as

Aptamers, NucleotideBiosensing TechniquesDrug Resistance, BacterialMethicillin-Resistant Staphylococcus aureusStaphylococcus aureusAnti-Bacterial AgentsColorimetryHumansVirulenceAnti-Bacterial AgentsAptamers, Nucleotideaptamerscolorimetric sensornanozymespattern recognitionpredictive diagnosticsS. aureussensors

Identifiers

PMID41672888
PMCPMC12980457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.